Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation: 11/11/2016, Revision: 21, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 30 June 2025 - 15:01

Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation: 11/11/2016, Revision: 21, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/glyxambi

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters